Tang, H.; Bai, Y.; Xiong, L.; Wei, Y.; Hu, W.; Xu, M.; Zhou, X.; Pan, G.; Zhang, L.; Zhu, M.; Tang, Z.; Yang, Z.; Zhou, X.; Cai, Y.; Lanuti, M.; Zhao, J. Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway. Preprints2020, 2020050077. https://doi.org/10.20944/preprints202005.0077.v1
Tang, H., Bai, Y., Xiong, L., Wei, Y., Hu, W., Xu, M., Zhou, X., Pan, G., Zhang, L., Zhu, M., Tang, Z., Yang, Z., Zhou, X., Cai, Y., Lanuti, M., & Zhao, J. (2020). Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway. Preprints. https://doi.org/10.20944/preprints202005.0077.v1
Tang, H., Michael Lanuti and Jinping Zhao. 2020 "Knockdown of CENPF Inhibits the Progression of Lung Adenocarcinoma Mediated by ERβ2/5 Pathway" Preprints. https://doi.org/10.20944/preprints202005.0077.v1
The signal transduction pathways of estrogen receptors (ER) mainly includes gene pathway and non-gene pathway. Studies have shown that the gene pathway of ER is related with the expression of nuclear proteins, and this is the key issue for our current research. With the GEO database analysis, Human centromere protein F (CENPF) is highly expressed in adenocarcinoma of lung (LUAD), and the co-expression of CENPF and ERβ was found in the nucleus of LUAD cells. Meanwhile, CENPF and ERβ2/5 were related with T stage and poor prognosis (P<0.05). Knockdown of CENPF gene significantly inhibited the biological effects of LUAD cells, the tumor growth of mice and the expression of ERβ2/5 (P<0.05). Further, group experiments showed that knockdown CENPF inhibits biological effects of LUAD cells mediated by ERβ pathway. All the results indicated that both CENPF and ERβ2/5 play important roles in the progression of LUAD, and knockdown of CENPF can inhibit the progression of LUAD by inhibiting the expression of ER2/5. Thus, the development of inhibitors against ERβ2/5 subtype and CENPF remained more effective in improving the therapeutic effect of LUAD.
centromere protein F (CENPF); Estrogen Receptor beta; Lung Adenocarcinoma (LUAD); WGCNA package; non-small cell lung cancer (NSCLC)
Medicine and Pharmacology, Oncology and Oncogenics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.